About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Atp1a3
ATPase, Na+/K+ transporting, alpha 3 polypeptide
MGI:88107
73 phenotypes from 8 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Atp1a3Myk/Atp1a3+
B6NCr.129S1-Atp1a3Myk
abnormal behavior J:180250, J:262367
abnormal enzyme/coenzyme activity J:180250
abnormal gait J:180250
abnormal habituation J:180250
abnormal hippocampus pyramidal cell morphology J:151948
abnormal neuron physiology J:180250
abnormal non-rapid eye movement sleep pattern J:180250
abnormal paradoxical sleep pattern J:180250
abnormal response to novel object J:180250
abnormal seizure response to inducing agent J:180250
abnormal sensitization to xenobiotic J:180250
abnormal sensorimotor gating J:180250
abnormal sleep pattern J:180250
abnormal spike wave discharge J:151948
abnormal startle reflex J:180250
abnormal temporal lobe morphology J:151948
convulsive seizures J:151948
decreased anxiety-related response J:180250
decreased body size J:151948
decreased body weight J:151948, J:262367
decreased frequency of paradoxical sleep J:180250
decreased prepulse inhibition J:180250
enhanced conditioned place preference behavior J:180250
environmentally induced seizures J:151948
impaired contextual conditioning behavior J:262367
impaired coordination J:262367
increased locomotor activity J:180250
increased thigmotaxis J:262367
normal nervous system phenotype J:151948
premature death J:151948
prolonged circadian behavior period J:180250
Atp1a3Myk/Atp1a3+
involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr
abnormal hippocampus pyramidal cell morphology J:151948
abnormal spike wave discharge J:151948
abnormal temporal lobe morphology J:151948
convulsive seizures J:151948
decreased body size J:151948
decreased body weight J:151948
environmentally induced seizures J:151948
normal nervous system phenotype J:151948
premature death J:151948
Atp1a3Myk/Atp1a3+
involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr * FVB/NCr
astrocytosis J:151948
microgliosis J:151948
Atp1a3Myk/Atp1a3+
Tg(Atp1a3)1Stcl/0
B6NCr.Cg-Atp1a3Myk Tg(Atp1a3)1Stcl
abnormal behavior J:262367
normal behavior/neurological phenotype J:262367
normal growth/size/body region phenotype J:262367
increased thigmotaxis J:262367
Atp1a3Myk/Atp1a3+
Tg(Atp1a3)1Stcl/0
involves: 129S1/SvImJ * C57BL/6 * SJL
normal behavior/neurological phenotype J:180250
normal nervous system phenotype J:151948
Atp1a3Myk/Atp1a3Myk
involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr
neonatal lethality, complete penetrance J:151948
Atp1a3Myk/Atp1a3tm1Ling
involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr
premature death J:151948
Atp1a3tm1.1Kwk/Atp1a3+
B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk
abnormal CNS synaptic transmission J:210870
abnormal xenobiotic pharmacokinetics J:210870
dystonia J:210870
enhanced coordination J:210870
hyperactivity J:210870
increased miniature inhibitory postsynaptic current frequency J:210870
normal nervous system phenotype J:210870
Atp1a3tm1.1Kwk/Atp1a3tm1.1Kwk
B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk
abnormal respiratory function J:210870
neonatal lethality, complete penetrance J:210870
Atp1a3tm1.1Tmklh/Atp1a3+
B6JRj.129S1-Atp1a3tm1.1Tmklh
abnormal action potential J:254463
abnormal behavior J:254463
abnormal dentate gyrus morphology J:254463
abnormal habituation to a new environment J:254463
abnormal hippocampus granule cell morphology J:254463
normal behavior/neurological phenotype J:254463
hyperactivity J:254463
impaired passive avoidance behavior J:254463
impaired spatial learning J:254463
increased susceptibility to pharmacologically induced seizures J:254463
increased susceptibility to xenobiotic induced morbidity/mortality J:254463
normal nervous system phenotype J:254463
preweaning lethality, incomplete penetrance J:254463
Atp1a3tm1.1Tmklh/Atp1a3tm1.1Tmklh
B6JRj.129S1-Atp1a3tm1.1Tmklh
neonatal lethality, complete penetrance J:254463
Atp1a3tm1b(EUCOMM)Hmgu/Atp1a3+
C57BL/6N-Atp1a3tm1b(EUCOMM)Hmgu/H
abnormal locomotor behavior J:211773
decreased anxiety-related response J:211773
hyperactivity J:211773
improved glucose tolerance J:211773
increased exploration in new environment J:211773
Atp1a3tm1b(EUCOMM)Hmgu/Atp1a3tm1b(EUCOMM)Hmgu
C57BL/6N-Atp1a3tm1b(EUCOMM)Hmgu/H
preweaning lethality, complete penetrance J:211773
Atp1a3tm1Ling/Atp1a3+
involves: 129 * Black Swiss
abnormal spatial learning J:117414
enhanced behavioral response to addictive substance J:117414
normal homeostasis/metabolism phenotype J:117414
hyperactivity J:117414
Atp1a3tm1Ling/Atp1a3tm1Ling
involves: 129 * Black Swiss
neonatal lethality, complete penetrance J:117414
Atp1a3tm1Mika/Atp1a3+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
abnormal gait J:264408
abnormal long-term object recognition memory J:264408
abnormal motor capabilities/coordination/movement J:264408
abnormal response to novel object J:264408
abnormal seizure response to inducing agent J:264408
decreased body size J:264408
decreased body weight J:264408
decreased exploration in new environment J:264408
decreased locomotor activity J:264408
dystonia J:264408
hemiplegia J:264408
impaired coordination J:264408
increased kindling response J:264408
limb grasping J:264408
premature death J:264408
seizures J:264408
short stride length J:264408
Atp1a3tm1Ute/Atp1a3+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal behavior J:262419
abnormal CNS synaptic transmission J:262419
abnormal long-term object recognition memory J:262419
ataxia J:262419
normal behavior/neurological phenotype J:262419
decreased anxiety-related response J:262419
decreased body weight J:262419
dystonia J:262419
normal growth/size/body region phenotype J:262419
hemiparesis J:262419
hemiplegia J:262419
hyperactivity J:262419
impaired coordination J:262419
increased kindling response J:262419
increased susceptibility to pharmacologically induced seizures J:262419
increased thermal nociceptive threshold J:262419
limb grasping J:262419
premature death J:262419
seizures J:262419
short stride length J:262419
tremors J:262419
Tg(Atp1a3)1Stcl/0
B6NCr.Cg-Tg(Atp1a3)1Stcl/Stcl
abnormal behavior J:262367
increased freezing behavior J:262367

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory